,MULTIPLE m v CHOIC
E
1. Knowledge of pharmacology aids the dental professional in m v m v m v m v m v m v m v
a. obtaining a patient’s health history. m v m v m v m v
b. administering drugs in the office. m v m v m v m v
c. handling emergency situations. m v m v
d. selection of a nonprescription medication. m v m v m v m v
e. All of the above. m v m v m v
ANS: E
All of the choices are true. Because many of our patients are being treated with drugs,
m v m v m v m v m v m v m v m v m v m v m v m v m v m v m v m
vkn owledge of pharmacology helps in understanding and interpreting patients’ responses to health
mv mv mv mv mv mv mv mv mv mv mv mv mv
hist ory questi ons. Knowledge of the therapeutic and adverse effects of medications obv
mv mv mv m v mv m v m v m v m v m v m v mv m v
iously help s in their prop er administration in the office. Emergency situations may be caused
m v mv mv mv m v mv mv m v mv mv mv m v m v mv mv
by drugs or t reated by drugs; t hus, knowledge of pharmacology is of great help, especially beca
m v mv mv mv mv mv mv mv m v mv mv mv mv mv mv mv mv mv
use a rapid res ponse is sometimes required. A clear understanding of the concepts of drug
mv mv mv mv mv mv m v m v m v m v m v m v m v m v m v
action, drug ha ndling by the body, and dr ug interactions will allow the dental practitioner t
m v m v m v mv m v m v m v m v m v mv mv mv mv mv mv mv mv
o make proper judg ments and grasp the concepts relevant to new drug therapies on the m
mv mv mv mv m v m v m v m v m v m v m v m v m v m v m v m v
arket.
DIF: Application
REF:
Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (
mv mv mv mv mv m v mv mv mv mv mv mv
Medic a tion Administration), Role of the Dental Hygienist (Emergency Situations), Rol
mv m v m v m v m v m v m v m v m v m v m v
e of the Dental Hygienis t (Nonprescription Medication) | pp. 2-3OBJ:
m v m v m v 1 mv mv mv mv mv mv mv
TOP: NBDHE, 6.0. Pharmacology m v m v
2. Which of the following statements is true regarding planning appointments?
m v m v m v m v m v m v m v m v m v
a. Whether or not patients are taking medication for systemic diseases is o
mv mv mv mv mv mv mv mv mv mv mv
f lit t le mv mv
consequence in the dental office. m v m v m v m v
b. Asthmatic patients should have dental appointments in the morning. m v m v m v m v m v m v m v m v
c. Diabetic patients usually have fewer problems with a morning appointme
mv mv mv mv mv mv mv mv mv
nt compared with afternoon appointments.
m v mv mv mv mv
d. Both B and C are true. m v m v m v m v m v
ANS: D
Asthmatic patients who experience dental anxiety should schedule their appointments wh
m v m v m v m v m v m v m v m v m v m v
en th ey ar e not rushed or under pressure early in the morning. Diabetic patients usually have rel
m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
atively fewer problems with a morning appointment. Patients taking medication for
mv m v m v m v m v m v m v m v m v m v m v m v
systemic disease s may requir e special handling in the dental office.
m v mv m v mv mv mv m v m v mv mv mv
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | m v m v m v m v m v m v m v
p. 3 OBJ: 1
m v TOP: NBDHE, 6.0. Pharmacology
m v m v m v m v
,3. Nutritional or herbal supplements m v m v m v
a. carry the U.S. Food and Drug Administration (FDA) approval for disease
mv mv mv mv mv mv mv mv mv mv m
stat e s. v mv m v
b. are not drugs. m v m v
c. can cause adverse effects. m v m v m v
d. will not interact with other drugs the patient may be taking.
m v m v m v m v m v m v m v m v m v m v
ANS: m v m v C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
nutrit i onal or herbal supplements do not carry FDA approval for treating disease states. These
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv m
vsupplemen ts are drugs and can cause adverse effects and interact with different drug
mv m v m v m v m v m v m v m v m v m v m v m v m v
s.
DIF: m v m Comprehension
v m v
REF: m v m Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
v m v m v m v m v m v m v m v m v m v m v
p. 3 m v m v OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
m v m v m v
4. Which type of drug name usually begins with a lowercase letter?
m v m v m v m v m v m v m v m v m v m v
a. Brand name mv
b. Code name m v
c. Generic name mv
d. Trade name m v
ANS: m v m v C
Before any drug is marketed, it is given a generic name that becomes the “official”
m v mv mv m v m v m v m v m v m v m v m v mv m v mv
m name of the dr ug. Each drug is assigned only one generic name selected by the U.S. A
v m v mv m v mv mv mv mv mv m v mv mv mv mv mv mv m v mv
dopted Name Cou ncil, and mv mv mv m v
the name is not capitalized. The brand name is equivalent to the trade na m v m v m v mv m v mv m v m v mv m v m v mv mv
me and i s capitalized. Alt hough the brand name is technically the name of the company
m v m v mv m v mv mv mv mv mv mv mv mv mv mv mv mv
marketing the pr oduct, this term is o ften used interchangeably with the trade name. Th
mv mv mv mv mv mv mv mv m v mv m v mv m v mv mv m v
e code name is the initia l term used within a pha rmaceutical company to refer to a dr
mv mv m v m v mv mv m v m v m v m v mv mv m v m v mv mv mv mv
ug while it is undergoing investig ation and is often a combinat
m v m v mv mv mv mv m v mv mv mv mv
ion of capital letters and numbers, the letters representing an m v m v m v m v m v m v m v m v m v
abbreviation of the company name. m v m v m v m v
DIF: Comprehension
REF:
Drug Names | p. 4 O mv mv mv mv mv
BJ: 3 TOP: m v mv
NBDHE, 6.0. Pharmacolog m v m v
y
5. A m v drug’s generic name is selected by the m v m v m v m v m v m v
a. pharmaceutical company manufacturing it. m v m v m v
b. Food and Drug Administration (FDA). m v m v m v m v
c. U.S. Adopted Name Council. m v m v m v
d. Federal Patent Office. m v m v
ANS: C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S.
mv mv mv m v m v mv mv mv mv mv m v mv mv mv mv m
vAdopte d Name Council. The generic name is not selected by the FDA or the Federal P
mv mv m v m v m v mv m v m v mv m v mv m v mv mv m v m v
atent Office. T he pha rmaceutical company manufacturing the drug clearly has an influence on t
m v m v mv mv mv mv mv mv mv mv mv mv mv mv mv
he generic name given its drug, but the final decision is not the company’s.
mv mv m v m v m v m v m v m v m v m v m v m v m v
DIF: Recall REF:
Drug m v Names m v | m v p. m v 4 OBJ:
m v
, 3 TOP: NBDHE, 6.0. Pharmacology
m v mv mv
6. Which of the following is true concerning generic and trade names of drugs?
m v m v m v m v m v m v m v m v m v m v m v m v
E
1. Knowledge of pharmacology aids the dental professional in m v m v m v m v m v m v m v
a. obtaining a patient’s health history. m v m v m v m v
b. administering drugs in the office. m v m v m v m v
c. handling emergency situations. m v m v
d. selection of a nonprescription medication. m v m v m v m v
e. All of the above. m v m v m v
ANS: E
All of the choices are true. Because many of our patients are being treated with drugs,
m v m v m v m v m v m v m v m v m v m v m v m v m v m v m v m
vkn owledge of pharmacology helps in understanding and interpreting patients’ responses to health
mv mv mv mv mv mv mv mv mv mv mv mv mv
hist ory questi ons. Knowledge of the therapeutic and adverse effects of medications obv
mv mv mv m v mv m v m v m v m v m v m v mv m v
iously help s in their prop er administration in the office. Emergency situations may be caused
m v mv mv mv m v mv mv m v mv mv mv m v m v mv mv
by drugs or t reated by drugs; t hus, knowledge of pharmacology is of great help, especially beca
m v mv mv mv mv mv mv mv m v mv mv mv mv mv mv mv mv mv
use a rapid res ponse is sometimes required. A clear understanding of the concepts of drug
mv mv mv mv mv mv m v m v m v m v m v m v m v m v m v
action, drug ha ndling by the body, and dr ug interactions will allow the dental practitioner t
m v m v m v mv m v m v m v m v m v mv mv mv mv mv mv mv mv
o make proper judg ments and grasp the concepts relevant to new drug therapies on the m
mv mv mv mv m v m v m v m v m v m v m v m v m v m v m v m v
arket.
DIF: Application
REF:
Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist (
mv mv mv mv mv m v mv mv mv mv mv mv
Medic a tion Administration), Role of the Dental Hygienist (Emergency Situations), Rol
mv m v m v m v m v m v m v m v m v m v m v
e of the Dental Hygienis t (Nonprescription Medication) | pp. 2-3OBJ:
m v m v m v 1 mv mv mv mv mv mv mv
TOP: NBDHE, 6.0. Pharmacology m v m v
2. Which of the following statements is true regarding planning appointments?
m v m v m v m v m v m v m v m v m v
a. Whether or not patients are taking medication for systemic diseases is o
mv mv mv mv mv mv mv mv mv mv mv
f lit t le mv mv
consequence in the dental office. m v m v m v m v
b. Asthmatic patients should have dental appointments in the morning. m v m v m v m v m v m v m v m v
c. Diabetic patients usually have fewer problems with a morning appointme
mv mv mv mv mv mv mv mv mv
nt compared with afternoon appointments.
m v mv mv mv mv
d. Both B and C are true. m v m v m v m v m v
ANS: D
Asthmatic patients who experience dental anxiety should schedule their appointments wh
m v m v m v m v m v m v m v m v m v m v
en th ey ar e not rushed or under pressure early in the morning. Diabetic patients usually have rel
m v mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv
atively fewer problems with a morning appointment. Patients taking medication for
mv m v m v m v m v m v m v m v m v m v m v m v
systemic disease s may requir e special handling in the dental office.
m v mv m v mv mv mv m v m v mv mv mv
DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling) | m v m v m v m v m v m v m v
p. 3 OBJ: 1
m v TOP: NBDHE, 6.0. Pharmacology
m v m v m v m v
,3. Nutritional or herbal supplements m v m v m v
a. carry the U.S. Food and Drug Administration (FDA) approval for disease
mv mv mv mv mv mv mv mv mv mv m
stat e s. v mv m v
b. are not drugs. m v m v
c. can cause adverse effects. m v m v m v
d. will not interact with other drugs the patient may be taking.
m v m v m v m v m v m v m v m v m v m v
ANS: m v m v C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of
mv mv mv mv mv mv mv mv mv mv mv mv mv mv
nutrit i onal or herbal supplements do not carry FDA approval for treating disease states. These
mv mv mv mv mv mv mv mv mv mv mv mv mv mv mv m
vsupplemen ts are drugs and can cause adverse effects and interact with different drug
mv m v m v m v m v m v m v m v m v m v m v m v m v
s.
DIF: m v m Comprehension
v m v
REF: m v m Role of the Dental Hygienist (Nutritional or Herbal Supplements) |
v m v m v m v m v m v m v m v m v m v m v
p. 3 m v m v OBJ: 1 TOP: NBDHE, 6.0. Pharmacology
m v m v m v
4. Which type of drug name usually begins with a lowercase letter?
m v m v m v m v m v m v m v m v m v m v
a. Brand name mv
b. Code name m v
c. Generic name mv
d. Trade name m v
ANS: m v m v C
Before any drug is marketed, it is given a generic name that becomes the “official”
m v mv mv m v m v m v m v m v m v m v m v mv m v mv
m name of the dr ug. Each drug is assigned only one generic name selected by the U.S. A
v m v mv m v mv mv mv mv mv m v mv mv mv mv mv mv m v mv
dopted Name Cou ncil, and mv mv mv m v
the name is not capitalized. The brand name is equivalent to the trade na m v m v m v mv m v mv m v m v mv m v m v mv mv
me and i s capitalized. Alt hough the brand name is technically the name of the company
m v m v mv m v mv mv mv mv mv mv mv mv mv mv mv mv
marketing the pr oduct, this term is o ften used interchangeably with the trade name. Th
mv mv mv mv mv mv mv mv m v mv m v mv m v mv mv m v
e code name is the initia l term used within a pha rmaceutical company to refer to a dr
mv mv m v m v mv mv m v m v m v m v mv mv m v m v mv mv mv mv
ug while it is undergoing investig ation and is often a combinat
m v m v mv mv mv mv m v mv mv mv mv
ion of capital letters and numbers, the letters representing an m v m v m v m v m v m v m v m v m v
abbreviation of the company name. m v m v m v m v
DIF: Comprehension
REF:
Drug Names | p. 4 O mv mv mv mv mv
BJ: 3 TOP: m v mv
NBDHE, 6.0. Pharmacolog m v m v
y
5. A m v drug’s generic name is selected by the m v m v m v m v m v m v
a. pharmaceutical company manufacturing it. m v m v m v
b. Food and Drug Administration (FDA). m v m v m v m v
c. U.S. Adopted Name Council. m v m v m v
d. Federal Patent Office. m v m v
ANS: C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S.
mv mv mv m v m v mv mv mv mv mv m v mv mv mv mv m
vAdopte d Name Council. The generic name is not selected by the FDA or the Federal P
mv mv m v m v m v mv m v m v mv m v mv m v mv mv m v m v
atent Office. T he pha rmaceutical company manufacturing the drug clearly has an influence on t
m v m v mv mv mv mv mv mv mv mv mv mv mv mv mv
he generic name given its drug, but the final decision is not the company’s.
mv mv m v m v m v m v m v m v m v m v m v m v m v
DIF: Recall REF:
Drug m v Names m v | m v p. m v 4 OBJ:
m v
, 3 TOP: NBDHE, 6.0. Pharmacology
m v mv mv
6. Which of the following is true concerning generic and trade names of drugs?
m v m v m v m v m v m v m v m v m v m v m v m v